“…The neurological symptoms of CS patients have been ascribed to defective repair in the brain of endogenous oxidative damage that blocks transcription (Kuraoka et al, 2000;Osterod et al, 2002;de Waard et al, 2003;Kyng et al, 2003;Tuo et al, 2003;Cline et al, 2004), but the more common oxidative base damages (8-oxo-G, 5-hydroxycytosine, thymine glycols) do not block transcription and are therefore not the culprits in neurodegeneration (Kathe et al, 2004). CSA and CSB cells are however different in their responses to oxidative damage, despite overlap in clinical symptoms (de Waard et al, 2004;D'Errico et al, 2007). The oxidative lesion 8-oxo-G does not appear to accumulate in CS autopsy material (Hayashi et al, 2005) despite the higher amounts of protein oxidation and lipid oxidation in the brains of CS patients (Hayashi et al, 2001) and crossing Cs-b mice with Ogg1 deficient mice did not enhance the neurological symptoms (Laposa et al, 2007b).…”